Cargando…

Recognition of adverse drug events in older hospitalized medical patients

OBJECTIVE: To assess medical teams’ ability to recognize adverse drug events (ADEs) in older inpatients. METHODS: The study cohort comprised 250 patients aged 65 years or older consecutively admitted to Internal Medicine wards of three hospitals in the Netherlands between April and November 2007. An...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klopotowska, Joanna E., Wierenga, Peter C., Smorenburg, Susanne M., Stuijt, Clementine C. M., Arisz, Lambertus, Kuks, Paul F. M., Dijkgraaf, Marcel G. W., Lie-A-Huen, Loraine, de Rooij, Sophia E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2012
Materias:	Pharmacoepidemiology and Prescription
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3536996/ https://www.ncbi.nlm.nih.gov/pubmed/22673927 http://dx.doi.org/10.1007/s00228-012-1316-4

Ejemplares similares

The effect of an active on-ward participation of hospital pharmacists in Internal Medicine teams on preventable Adverse Drug Events in elderly inpatients: protocol of the WINGS study (Ward-oriented pharmacy in newly admitted geriatric seniors)
por: Klopotowska, Joanna E, et al.
Publicado: (2011)

Adverse Drug Events in Older Hospitalized Patients: Results and Reliability of a Comprehensive and Structured Identification Strategy
por: Klopotowska, Joanna E., et al.
Publicado: (2013)

The effect of structured medication review followed by face-to-face feedback to prescribers on adverse drug events recognition and prevention in older inpatients – a multicenter interrupted time series study
por: Klopotowska, Joanna E., et al.
Publicado: (2022)

The potential of training specialist oncology nurses in real-life reporting of adverse drug reactions
por: Reumerman, M., et al.
Publicado: (2021)

Sex differences in spontaneous reports on adverse drug events for common antihypertensive drugs
por: Rydberg, Diana M, et al.
Publicado: (2018)

An analysis of marketing authorisation applications via the mutual recognition and decentralised procedures in Europe
por: Ebbers, Hans C., et al.
Publicado: (2015)

Vitamin D deficiency as adverse drug reaction? A cross-sectional study in Dutch geriatric outpatients
por: van Orten-Luiten, A. C. B., et al.
Publicado: (2016)

Potentially inappropriate prescribing and adverse drug reactions in the elderly: a population-based study
por: Hedna, Khedidja, et al.
Publicado: (2015)

Knowledge, attitudes and practices of health care professionals towards adverse drug reaction reporting in public sector primary health care facilities in a South African district
por: Haines, H. M., et al.
Publicado: (2020)

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
por: van Hunsel, Florence, et al.
Publicado: (2010)

Renal ischemic adverse drug events related to tranexamic acid in women of child-bearing age: an analysis of pharmacovigilance data
por: Stämpfli, Dominik, et al.
Publicado: (2020)

A patient-centred web-based adverse drug reaction reporting system identifies not yet labelled potential safety issues
por: Hasford, J., et al.
Publicado: (2021)

Incidence, preventability, and causality of adverse drug reactions at a university hospital emergency department
por: Kauppila, Mirjam, et al.
Publicado: (2020)

Fatal adverse events of rivaroxaban combined with aspirin: an analysis using data from VigiBase
por: Zhang, Qingxia, et al.
Publicado: (2022)

Unintentional guideline deviations in hospitalized patients with two or more antithrombotic agents: an intervention study
por: van Uden, Renate C. A. E., et al.
Publicado: (2021)

Reducing the noise in signal detection of adverse drug reactions by standardizing the background: a pilot study on analyses of proportional reporting ratios-by-therapeutic area
por: Grundmark, Birgitta, et al.
Publicado: (2014)

Why hospital-based healthcare professionals do not report adverse drug reactions: a mixed methods study using the Theoretical Domains Framework
por: Li, Raymond, et al.
Publicado: (2022)

Evaluation of patients’ experiences with antidepressants reported by means of a medicine reporting system
por: van Geffen, E. C. G., et al.
Publicado: (2007)

Metabolic acidosis caused by concomitant use of paracetamol (acetaminophen) and flucloxacillin? A case report and a retrospective study
por: Berbee, J. K., et al.
Publicado: (2017)

Number of medications and adverse drug events by unintentional poisoning among older adults in consideration of inappropriate drug use: a Swedish population-based matched case-control study
por: Rausch, Christian, et al.
Publicado: (2017)

Relationship between drug burden and physical and cognitive functions in a sample of nursing home patients with dementia
por: Sanders, L. M. J., et al.
Publicado: (2017)

How useful are prescribing indicators based on the DU90% method to distinguish the quality of prescribing between pharmacotherapy audit meetings with different levels of functioning?
por: Teichert, Martina, et al.
Publicado: (2007)

The clinical and educational outcomes of an inter-professional student-led medication review team, a pilot study
por: Reumerman, Michael O., et al.
Publicado: (2020)

Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson’s disease
por: Arbouw, Maurits E. L., et al.
Publicado: (2009)

Majority of drug-related problems identified during medication review are not associated with STOPP/START criteria
por: Verdoorn, Sanne, et al.
Publicado: (2015)

Risk factors for severe bleeding events during warfarin treatment: the influence of sex, age, comorbidity and co-medication
por: Rydberg, Diana M., et al.
Publicado: (2020)

Are multidose drug dispensing systems initiated for the appropriate patients?
por: Mertens, Bram J., et al.
Publicado: (2018)

Do medical students copy the drug treatment choices of their teachers or do they think for themselves?
por: Tichelaar, J., et al.
Publicado: (2009)

The role of Periodic Safety Update Reports in the safety management of biopharmaceuticals
por: Ebbers, Hans C., et al.
Publicado: (2012)

Frequency of laboratory measurement and hyperkalaemia in hospitalised patients using serum potassium concentration increasing drugs
por: Uijtendaal, Esther V., et al.
Publicado: (2011)

Dopamine agonists and ischemic complications in Parkinson’s disease: a nested case–control study
por: Arbouw, Maurits E. L., et al.
Publicado: (2011)

Predictors of orphan drug approval in the European Union
por: Heemstra, Harald E., et al.
Publicado: (2008)

The nocebo effect challenges the non-medical infliximab switch in practice
por: Boone, N. W., et al.
Publicado: (2018)

Outcomes of off-label drug uses in hospitals: a multicentric prospective study
por: Danés, I., et al.
Publicado: (2014)

Off-label use of dexmedetomidine in paediatric anaesthesiology: an international survey of 791 (paediatric) anaesthesiologists
por: van Hoorn, Camille E., et al.
Publicado: (2020)

A novel approach to teaching pharmacotherapeutics—feasibility of the learner-centered student-run clinic
por: Dekker, Ramon S., et al.
Publicado: (2015)

Trends in inpatient antiparkinson drug use in the USA, 2001–2012
por: Crispo, James A. G., et al.
Publicado: (2015)

Higher FORTA (Fit fOR The Aged) scores are associated with poor functional outcomes, dementia, and mortality in older people
por: Pazan, Farhad, et al.
Publicado: (2022)

Lack of association between proton pump inhibitor use and brain aging: a cross-sectional study
por: Ahn, Nayeon, et al.
Publicado: (2021)

Switching from a traditional undergraduate programme in (clinical) pharmacology and therapeutics to a problem-based learning programme
por: Brinkman, David J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_heebs476otoscng44sbiok0uha